|
SLC7A6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.660000E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.822300E-03 |
| Normal-vs-Stage2 |
1.632030E-01 |
| Normal-vs-Stage3 |
1.010020E-02 |
| Normal-vs-Stage4 |
5.187700E-02 |
| Stage1-vs-Stage2 |
2.865000E-01 |
| Stage1-vs-Stage3 |
9.623000E-01 |
| Stage1-vs-Stage4 |
5.160200E-01 |
| Stage2-vs-Stage3 |
3.243400E-01 |
| Stage2-vs-Stage4 |
6.985200E-01 |
| Stage3-vs-Stage4 |
5.497000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.718400E-03 |
| Normal-vs-AfricanAmerican |
1.566380E-02 |
| Normal-vs-Asian |
7.595000E-01 |
| Caucasian-vs-AfricanAmerican |
6.536200E-01 |
| Caucasian-vs-Asian |
1.099360E-01 |
| AfricanAmerican-vs-Asian |
8.224000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.399960E-02 |
| Normal-vs-Female |
8.679200E-03 |
| Male-vs-Female |
6.801600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.080400E-02 |
| Normal-vs-Age(41-60Yrs) |
4.681500E-02 |
| Normal-vs-Age(61-80Yrs) |
4.741300E-03 |
| Normal-vs-Age(81-100Yrs) |
2.999600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.800400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.870400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.527800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.058850E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.527170E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.700000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.463000E-01 |
| Normal-vs-Grade 2 |
5.923800E-03 |
| Normal-vs-Grade 3 |
6.535100E-03 |
| Normal-vs-Grade 4 |
1.684420E-01 |
| Grade 1-vs-Grade 2 |
2.618400E-01 |
| Grade 1-vs-Grade 3 |
2.355400E-01 |
| Grade 1-vs-Grade 4 |
7.265000E-01 |
| Grade 2-vs-Grade 3 |
9.309200E-01 |
| Grade 2-vs-Grade 4 |
1.651840E-01 |
| Grade 3-vs-Grade 4 |
2.168600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.579900E-03 |
| Normal-vs-ccB subtype |
6.330100E-02 |
| ccA subtype-vs-ccB subtype |
9.435900E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.952000E-02 |
| Normal-vs-N1 |
6.636800E-01 |
| N0-vs-N1 |
4.497200E-01 |
|
|
